Author

Marco Niedergethmann

Observed names: M Niedergethmann, M. Niedergethmann, M., Niedergethmann, Marco Niedergethman, Niedergethmann, Marco

Observed institutions: University of Bonn, German Cancer Research Center, Heidelberg University, German Cancer Society, University Hospital Münster, Salzburger Landeskliniken, Alfried Krupp Hospital, University Medical Centre Mannheim, University Hospital Carl Gustav Carus, Medizinische Fakultät Mannheim, Stiftung Charité, Charité – Universitätsmedizin Berlin

ORCID: 0000-0003-1803-4973

Observed ORCID: 0000-0003-1803-4973

OpenAlex ID: A5064042633

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

2007 · Helmut Oettle, Stefan Post, et al. · JAMA · 2,448

Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer

2013 · Helmut Oettle, Peter Neuhaus, et al. · JAMA · 1,845

Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial

2011 · Markus K Diener, Christoph M Seiler, et al. · The Lancet · 562

Long‐term Results of Partial Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreatic Head: 25‐Year Experience

2003 · Axel Richter, Marco Niedergethmann, et al. · World Journal of Surgery · 402

Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767)

2015 · Tobias Keck, U. F. Wellner, et al. · Annals of Surgery · 350

Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes

2012 · Christof Winter, Glen Kristiansen, et al. · PLoS Computational Biology · 208

PDF

High Expression of Vascular Endothelial Growth Factor Predicts Early Recurrence and Poor Prognosis after Curative Resection for Ductal Adenocarcinoma of the Pancreas

2002 · Marco Niedergethmann, Ralf Hildenbrand, et al. · Pancreas · 191

Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial

2017 · Markus K Diener, Felix J Hüttner, et al. · The Lancet · 170

Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis: 5-year results of a multicentre, randomised controlled trial

2022 · Tilman Reiff, Hans-Henning Eckstein, et al. · The Lancet Neurology · 156

Pathohistological Subtype Predicts Survival in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

2013 · Marius Distler, Stephan Kersting, et al. · Annals of Surgery · 145

Intraductal Papillary Mucinous Tumors of the Pancreas: Biology, Diagnosis, and Treatment

2010 · Robert Grützmann, Marco Niedergethmann, et al. · The Oncologist · 142

A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer

2006 · Helmut Friess, Jan M Langrehr, et al. · BMC Cancer · 127

PDF

A randomised, prospective, multicenter, phase III trial of gemcitabine, 5-fluorouracil (5-FU), folinic acid vs. gemcitabine alone in patients with advanced pancreatic cancer

2005 · H. Riess, A. Helm, et al. · Journal of Clinical Oncology · 103

Pancreatic Acinar Cell Carcinoma: A Multi-institutional Study

2009 · Jesus M. Matos, C. Max Schmidt, et al. · Journal of Gastrointestinal Surgery · 96

Prognostic Impact of Cysteine Proteases Cathepsin B and Cathepsin L in Pancreatic Adenocarcinoma

2004 · Marco Niedergethmann, Birgit Wostbrock, et al. · Pancreas · 84

Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities

2022 · Nader Hirmas, Rainer Hamacher, et al. · Journal of Nuclear Medicine · 79

PDF

Outcome of Invasive and Noninvasive Intraductal Papillary‐Mucinous Neoplasms of the Pancreas (IPMN): A 10‐year Experience

2008 · Marco Niedergethmann, Robert Grützmann, et al. · World Journal of Surgery · 74

Benefit of venous resection for ductal adenocarcinoma of the pancreatic head

2002 · Mark Hartel, Marco Niedergethmann, et al. · The European Journal of Surgery · 74

Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model

2007 · M Niedergethmann, F Alves, et al. · British Journal of Cancer · 69

PDF

Factors Predicting Long-Term Survival Following Pancreatic Resection for Ductal Adenocarcinoma of the Pancreas: 40 Years of Experience

2013 · Niloufar Dusch, Christel Weiss, et al. · Journal of Gastrointestinal Surgery · 68

Angiogenesis and Cathepsin Expression Are Prognostic Factors in Pancreatic Adenocarcinoma after Curative Resection

2000 · Marco Niedergethmann, Ralf Hildenbrand, et al. · International Journal of Gastrointestinal Cancer · 65

Early and enduring nutritional and functional results of pylorus preservation vs classic Whipple procedure for pancreatic cancer

2006 · Marco Niedergethmann, Edward Shang, et al. · Langenbeck s Archives of Surgery · 63

International Study Group of Pancreatic Surgery Definitions for Postpancreatectomy Complications: Applicability at a High-Volume Center

2017 · N. Dusch, A. Lietzmann, et al. · Scandinavian Journal of Surgery · 58

PDF

Randomized controlled trial: comparison of two surgical techniques for closing the wound following ileostomy closure: purse string vs direct suture

2013 · N. Dusch, D. Goranova, et al. · Colorectal Disease · 56

Amplification of the Urokinase-Type Plasminogen Activator Receptor (uPAR) Gene in Ductal Pancreatic Carcinomas Identifies a Clinically High-Risk Group

2009 · Ralf Hildenbrand, Marco Niedergethmann, et al. · American Journal Of Pathology · 54

PDF

Works count: 150

Citation count: 8,500

H-index: 33

I10-index: 51